Soligenix
SNGX
#10244
Rank
A$20.98 M
Marketcap
A$2.08
Share price
12.20%
Change (1 day)
-54.20%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -A$19.38 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$14.1 Million a decrease over its 2023 earnings that were of -A$11.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.38 Million37.52%
2024 -A$14.1 Million22.96%
2023 -A$11.47 Million-45.74%
2022 -A$21.12 Million11.88%
2021 -A$18.88 Million-32.37%
2020 -A$27.92 Million83.18%
2019 -A$15.24 Million11.57%
2018 -A$13.66 Million19.29%
2017 -A$11.45 Million33%
2016 -A$8.61 Million-19.7%
2015 -A$10.72 Million5.16%
2014 -A$10.2 Million
2010 -A$11.51 Million26.12%
2009 -A$9.13 Million75.1%
2008 -A$5.21 Million-45.38%
2007 -A$9.54 Million-22.84%
2006 -A$12.37 Million66.15%
2005 -A$7.44 Million-16.65%
2004 -A$8.93 Million13.28%
2003 -A$7.88 Million-11.88%
2002 -A$8.95 Million-59.44%
2001 -A$22.05 Million378.18%
2000 -A$4.62 Million-38.53%
1999 -A$7.51 Million-18.43%
1998 -A$9.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cleveland BioLabs
CBLI
-A$4.15 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.71 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$17.86 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.83 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$62.96 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.38 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.67 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel